Inhibiting TGFβ, however, can be problematic; this pleiotropic cytokine has multiple roles in normal physiology as well as tumor-suppressive effects, and its targeting has led to on-target cardiac toxicities in preclinical studies, as well as the development of cutaneous tumors in human trials (18, 55). This evidence concerns the gene TGFB1 and neoplasm.